NIH awards $15.8 million to UC Davis Health for major Hispanic-Latino brain health study
Grant and Award Announcement
Updates every hour. Last Updated: 25-May-2026 22:16 ET (26-May-2026 02:16 GMT/UTC)
Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for only about 20% of patients, though, and doctors still struggle to predict who will benefit.
A Rutgers Cancer Institute study in Cell Reports Medicine promises help with both those problems. It identifies a protein that appears to predict drug response, and it shows that pairing immunotherapy with a second type of drug dramatically improves survival in mice.
A review finds that antibiotic resistance genes—capable of undermining modern medicine—can travel through the air across both cities and farmland, and argues that airborne spread represents an overlooked public health risk.
A new study, led by researchers at Case Western Reserve University’s School of Medicine, found that vitamin B3 derivatives may be doing more harm than good—helping cancer cells survive and resist treatment.
NCCN brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually. This year’s event featured educational sessions on the latest breakthroughs in cancer prevention and treatment, clinical guidelines updates, guidance for improving cancer center operations, plus panel discussions on critical issues in care delivery.
Autism BrainNet today released new survey findings revealing a significant disconnect between Americans’ strong support of autism research and their limited understanding of the role postmortem brain donation plays in advancing it. The survey found that 70 percent of respondents had never heard of brain donation, despite 92 percent agreeing that analysis of the autistic brain is extremely or very important to advance research.